Does IXEKIZUMAB Cause Injection site induration? 177 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 177 reports of Injection site induration have been filed in association with IXEKIZUMAB (TALTZ). This represents 0.5% of all adverse event reports for IXEKIZUMAB.
177
Reports of Injection site induration with IXEKIZUMAB
0.5%
of all IXEKIZUMAB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Injection site induration From IXEKIZUMAB?
Of the 177 reports, 3 (1.7%) required hospitalization.
Is Injection site induration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IXEKIZUMAB. However, 177 reports have been filed with the FAERS database.
What Other Side Effects Does IXEKIZUMAB Cause?
Injection site pain (3,799)
Psoriasis (2,818)
Drug ineffective (2,759)
Injection site erythema (2,144)
Injection site reaction (1,701)
Injection site swelling (1,615)
Incorrect dose administered (1,032)
Covid-19 (861)
Product dose omission issue (832)
Therapy interrupted (796)
What Other Drugs Cause Injection site induration?
ETANERCEPT (1,451)
NALTREXONE (866)
ADALIMUMAB (577)
GLATIRAMER (382)
DUPILUMAB (376)
INTERFERON BETA-1A (254)
EVOLOCUMAB (229)
ENBREL (218)
LEUPROLIDE (207)
HYDROXYPROGESTERONE CAPROATE (158)
Which IXEKIZUMAB Alternatives Have Lower Injection site induration Risk?
IXEKIZUMAB vs JAKAFI
IXEKIZUMAB vs JANUMET
IXEKIZUMAB vs JANUVIA
IXEKIZUMAB vs JETREA
IXEKIZUMAB vs JUXTAPID